The Franklin Templeton XRP Exchange-Traded Fund (ETF) has appeared on the Depository Trust & Clearing Corporation (DTCC) website under the ticker XRPZ, as confirmed by Cryptopolitan early Friday. The listing is only a preparatory step and does not indicate approval or active trading start. The DTCC website is a database that lists the names of […]The Franklin Templeton XRP Exchange-Traded Fund (ETF) has appeared on the Depository Trust & Clearing Corporation (DTCC) website under the ticker XRPZ, as confirmed by Cryptopolitan early Friday. The listing is only a preparatory step and does not indicate approval or active trading start. The DTCC website is a database that lists the names of […]

Franklin Templeton’s proposed XRP ETF inches closer to approval

The Franklin Templeton XRP Exchange-Traded Fund (ETF) has appeared on the Depository Trust & Clearing Corporation (DTCC) website under the ticker XRPZ, as confirmed by Cryptopolitan early Friday. The listing is only a preparatory step and does not indicate approval or active trading start.

The DTCC website is a database that lists the names of live exchange-traded funds and those in the pre-launch phase, but it only does so as a formality and does not track the likelihood of approvals ahead of their official market debut.

Franklin Templeton’s XRPZ listed on DTCC post-S-1 filing amendment

Bloomberg ETF analyst James Seyffart had reported on Tuesday that Franklin Templeton submitted an amended Form S-1 registration statement for the XRP fund. The changes made include the shortened “8(a)” language, a legal “loophole” that allows the registration to automatically take effect after 20 days without a direct US Securities and Exchange (SEC) sign-off, unless the agency intervenes.

The updated prospectus sent to the regulator on Tuesday specifies that the Franklin XRP Trust will hold XRP tokens as its primary asset and will track the digital asset’s market performance. Once approved, the ETF is expected to list on the Cboe BZX Exchange.

Franklin Templeton’s filing is among several similar ETF submissions and proposed filing changes made in early November. Bitwise and Canary Capital filed amendments last week, removing the traditional “delaying amendment” clause to limit the SEC’s ability to control the timeline of approval.

Grayscale Investments also lodged its second amendment (Amendment No. 2) to its own XRP-related Form S-1 on Monday. 

Crypto In America podcast host and former FOX News correspondent Eleanor Terrett said Canary Capital could see its XRP ETF approved by November 13, pending final clearance from Nasdaq through its 8-A filing, and whether the government shutdown ends sooner. 

“The government reopening could affect the timing, potentially moving it up if the filing is complete and the SEC is satisfied, or back if staff propose additional comments,” she wrote on X in late October.

The strategy deployed by Franklin Templeton copies that of issuers behind Solana (SOL), Litecoin (LTC), and Hedera (HBAR) ETFs, which successfully launched under similar automatic-effect rules last month.

Just before the 38-day-long and counting US government shutdown began, these ETFs managed to clear the regulatory process and list without formal SEC approval delays. Bitwise’s BSOL ETF recorded an impressive $56 million in first-day trading volume, the highest debut among more than 850 ETFs launched to date.

Franklin Templeton ‘optimistic’ on digital asset market products

Franklin Templeton, the seven-decade-old financial firm that manages over $1.5 trillion in global assets, is among the most active traditional finance entities to launch crypto-based investment vehicles.

Earlier this year, it debuted spot EZBC (Bitcoin) and EZET (Ethereum) funds, which collectively attracted over $500 million in institutional capital within their first quarter. 

The New York-based company has also started a blockchain-based project in Hong Kong, launching the region’s first tokenized money-market fund together with the Hong Kong Monetary Authority (HKMA) under its new Fintech 2030 roadmap.

The Franklin OnChain US Government Money Fund is registered in Luxembourg and backed by short-term US Treasuries, using blockchain tokens in place of investor shares. Working with HSBC and OSL Group, one of Hong Kong’s 11 licensed virtual-asset platforms, Franklin Templeton is testing instant settlements through Project Ensemble, an HKMA sandbox for tokenized deposits. 

HSBC executives believe the tokenized platform could help bump fund flows and improve cross-system interoperability, which could later influence ETF operations in tokenized form. 

XRP ETF crosses $100 million in AUM after weeks of trading

Away from pending ETF approvals, the live REX-Osprey XRP ETF (XRPR), launched on September 18, surpassed $100 million in assets under management (AUM) within just five weeks, according to the issuer’s report in late October.

Outside US markets, the Hashdex Nasdaq XRP ETF (XRPH11), the world’s first spot XRP ETF, listed in Brazil, has accumulated approximately 7.17 billion Brazilian reais (around $1.33 billion) in total assets from over 300,000 investors, per statistics shared by the ETF provider’s website.

Sharpen your strategy with mentorship + daily ideas - 30 days free access to our trading program

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0632
$2.0632$2.0632
-1.58%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23